blue cross blue shield reverse course on glp 1 Medicare Bridge Program Explained: GLP-1 Medications for Weight Loss independence blue cross glp 1

A Lilly spokesperson reportedly said the companys top priority is patient safety, and that it actively [engages] in monitoring, evaluating, and reporting safety information for its medications

The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis later reported 28.7% mean weight loss at 68 weeks with retatrutide 12 mg/week, and identified a dose-related dysesthesia (nerve-tingling) signal in 8.8% of 9 mg and 20.9% of 12 mg patients (Bays et al., 2025)

Hirsch, I

Supplementing with NAD+ As we age, our NAD levels naturally decline reducing our cells optimal function

Like other obesity pharmacotherapy, naltrexone/bupropion is indicated for BMI 30 kg/m 2 or 27 kg/m 2 in association with other obesity-related co-morbidities